Search

everythinglearnresearchcommunity

for

Search:↓

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

HGF/SF increases skin melanocytes but doesn't change melanin type or amount.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Most people using biotin don't see skin improvements, and it may affect lab tests, so doctors shouldn't suggest it without confirming a deficiency.

Laser hair-comb therapy doesn't improve male-pattern hair loss.

Most UK dental schools don't teach non-surgical facial aesthetics, but dentists have a good knowledge base to provide these services.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

A girl's severely tangled hair couldn't be fixed and had to be cut due to a rare condition called plica neuropathica.

Bright light during the day doesn't change most human clock genes but may slightly increase Rev-erb-ß.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

DanGuiBoHyulTangGami-Bang helps hair growth but doesn't extend the growth period or affect hair follicle cells significantly.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Removing part of the eyelid usually doesn't change the number of eyelashes.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Glycosaminoglycans help heal wounds but aren't yet ready for clinical use.

Vitamin D levels in hair don't match those in blood, so hair isn't a reliable indicator of Vitamin D status.

Most people with hair loss haven't used treatment products and are only somewhat satisfied with their options, highlighting a need for better management programs and marketing.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

Lead and selenium levels don't cause premature graying.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Looking at tissue characteristics isn't reliable for telling apart basal cell carcinoma from certain benign skin tumors.

Most minoxidil products on Amazon don't provide safety or side effect information.

Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.

Green coffee bean extract didn't grow hair but reduced a hair loss-related enzyme in rats.

Older adults in Puerto Rico often couldn't be tested for hair cortisol due to refusal or lack of hair, with race and hair products affecting results.

The authors agree they didn't discuss the risks of too much micronutrients and value the focus on biotin deficiency signs and treatment effectiveness.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.